NEW YORK (GenomeWeb) – Becton Dickinson today reported a nearly 40 percent jump in its fiscal fourth quarter revenues, reflecting the company's acquisition of medical technology firm CareFusion earlier this year.

"We are very pleased with our strong finish to the year as a combined entity," BD CFO Christopher Reidy said during a conference call after the release of the company's earnings. "We significantly expanded our margins and captured approximately $50 million in synergy cost savings." 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.